Jill Thomsen
About Jill Thomsen
Jill Thomsen serves as the Senior Vice President and Chief Financial Officer at Nektar Therapeutics in San Francisco, California, a position she has held since 2022. She holds a Bachelor of Arts in Business Economics from Colorado College and a Master of Accountancy from the University of Denver's Daniels College of Business.
Work at Nektar Therapeutics
Jill Thomsen serves as the Senior Vice President and Chief Financial Officer at Nektar Therapeutics. She has held this position since 2022, contributing to the company's financial strategy and operations. Nektar Therapeutics is based in San Francisco, California, and focuses on developing innovative therapies to treat serious diseases. In her role, Thomsen oversees financial planning, reporting, and risk management, ensuring the company's financial health and compliance.
Education and Expertise
Jill Thomsen has a solid educational background in business and finance. She studied Business Economics at Colorado College, where she earned a Bachelor of Arts degree. Additionally, she pursued a Master of Accountancy (MAcc) at the University of Denver's Daniels College of Business. Her academic qualifications provide her with a strong foundation in financial principles and practices, which she applies in her current role.
Background
Jill Thomsen has a diverse background in finance and accounting. Her educational journey includes two years of study at both Colorado College and the University of Denver, where she developed expertise in business economics and accounting. This background has equipped her with the skills necessary for her leadership role in the financial sector.
Professional Experience
Before joining Nektar Therapeutics, Jill Thomsen accumulated significant experience in finance and accounting roles. Her expertise encompasses financial management, strategic planning, and operational oversight. This experience has been instrumental in her current position as Chief Financial Officer, where she plays a key role in guiding the company's financial direction.